Home/Filings/4/0001209191-22-003013
4//SEC Filing

Harrison Rosemary 4

Accession 0001209191-22-003013

CIK 0001750019other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 6:57 AM ET

Size

5.3 KB

Accession

0001209191-22-003013

Insider Transaction Report

Form 4
Period: 2022-01-10
Harrison Rosemary
Chief Business & Strategy
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-10+191,102191,102 total
    Exercise: $4.04Exp: 2032-01-09Common Stock (191,102 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 10, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1
  • filerCIK 0001838046

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:57 AM ET
Size
5.3 KB